EPA0047 Cryo-EM analysis provide structural insights for broad HIV-1 neutralization by a heavy chain matured antibody from an Indian pediatric elite-neutralizer ​E-posterHost immune responses, vaccines and immunotherapies
EPA0048 Feasibility of iNKT cells as an immunotherapeutic HIV cure interventionE-posterHost immune responses, vaccines and immunotherapies
EPA0049 HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells and cAMP-dependent efferocytosisE-posterHost immune responses, vaccines and immunotherapies
EPA0050 Post-treatment controllers exhibit distinct CD8+ T cell features before and after ART interruptionE-posterHost immune responses, vaccines and immunotherapies
EPA0051 Specific immunological response after administration of anti-meningococcal quadrivalent conjugate vaccine MENVEO® in a population of vertically HIV-infected children, adolescents and young adultsE-posterHost immune responses, vaccines and immunotherapies
EPA0052 Costimulation with MAdCAM and retinoic acid generates the formation of gut tissue resident memory CD8 T cells that express E-cadherinE-posterHost immune responses, vaccines and immunotherapies
LBEPA02 Immune responses to respiratory syncytial virus among HIV-exposed uninfected infants from the United States correlate with maternal inflammation during pregnancyE-posterHost immune responses, vaccines and immunotherapies
LBEPA04 HIV-1-induced isoformic PD-1 undermines Env-specific B cell responseE-posterHost immune responses, vaccines and immunotherapies
LBEPA05 Preserved frequency and cytotoxicity of HIV-specific follicular CD8 T cells associates with reduced viral reservoir in individuals treated during primary HIV infectionE-posterHost immune responses, vaccines and immunotherapies
LBEPA07 In-depth characterization of functional anti-Env antibody responses during early or late viral suppression with fostemsavir in treatment-experienced patientsE-posterHost immune responses, vaccines and immunotherapies
821 - 830 of 1427 items